Crescent Biopharma to present
Analysis based on 6 articles · First reported Jun 02, 2026 · Last updated Jun 02, 2026
The market may react positively to GT Biopharma's presentations at these conferences, as it provides an opportunity for investors to learn more about the company's pipeline and future prospects. Increased investor interest could lead to a rise in GT Biopharma's stock price.
GT Biopharma, a clinical-stage biotechnology company, announced its management is scheduled to present at two investor conferences in June 2026. These include the 2026 Jefferies Global Healthcare Conference on June 3 in New York and the Goldman Sachs 47th Annual Global Healthcare Conference on June 8 in Miami. The presentations will be fireside chats, and live webcasts will be available on GT Biopharma's investor relations website, with replays accessible for 90 days. The company aims to build a world-leading oncology company and is focused on advancing therapies for cancer patients, including a PD-1 x VEGF bispecific antibody and novel antibody-drug conjugates.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard